Our Sponsors

  • Vivus ready to rock

     Future is bright for this company.

    Hey Guys,

    Vivus is to webcast discussion for the Phase 3 results of its much awaited product Qnexa. it is believed that the company is going to present positive data and the shares are set to rise. There has been a lot of talks about this company and after hour price has rised. This is a stock where you can take benefit of the rise before tha actual news. It will rise much in anticipation of FDA approval and rumours coming from all sides for few days. Do your research in such stocks where they present good results and wait for FDA approval. Search all relevant news and make a wise decision. Try to get it below 8 to 8.1 tomorrow.

    Do share your thoughts, trades and comments.

    Vivus to Host Conference Call and Webcast Discussion of  Qnexa Phase 3 results

    VIVUS, Inc. (Nasdaq: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, plans to announce the results from the EQUIP and CONQUER Qnexa(TM) phase 3 obesity clinical trials on September 9th prior to market open. The announcement will be followed by a webcast and conference call at 8:00 a.m. Eastern time.  More News Here

    We are here to make money and we will succeed.

    God Bless,

    Be Rich.


Leave a Reply

Latest Posts